Recombinant APP (Donanemab Biosimilar) antibody
Research Grade
Reactivity: Human
ELISA, WB
Host: Mammalian Cells
Monoclonal
unconjugated
Recombinant Antibody
-
- Target
- APP (Donanemab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
- Host
-
Mammalian Cells
- Expression System
- Mammalian cells
- Clonality
- Monoclonal
- Application
- ELISA, Western Blotting (WB)
- Purpose
- Donanemab Biosimilar - Anti-APP mAb
- Characteristics
- Antibody Type: IgG1-kappa
- Purification
- Recombinant antibody expressed in mammalien cells and purified.
- Grade
- Research Grade
- Isotype
- IgG1 kappa
-
- Restrictions
- For Research Use only
-
- Buffer
- PBS buffer pH 7.5
- Storage
- -80 °C
- Storage Comment
- store at -80°C
-
- Target
- APP (Donanemab Biosimilar)
- Target Type
- Biosimilar
- Background
-
LY3002813
Donanemab is a humanized IgG1 monoclonal antibody directed at an N‐terminal pyroglutamate amyloid beta (Aβ) epitope. Donanemab has the potential for early Alzheimer's disease research.
-
You are here:
